Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10909208 | Leukemia Research | 2012 | 6 Pages |
Abstract
AML presentation and treatment differed in black and white patients, but OS was similar. Black patients appear to have barriers to clinical trial participation and HSCT, and there may be barriers to tertiary care referral for black males.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jason Bierenbaum, Amy J. Davidoff, Yi Ning, Michael L. Tidwell, Ivana Gojo, Maria R. Baer,